EUVIMEDEUVIMED entdecken
Crossref

Infill-Modulated, Bioerodible, and Biocompatible Ocular Inserts for Tunable Acyclovir Release via Direct Powder Extrusion 3D Printing

Ankan Das, Srushti Lekurwale, Shriram Mahajan iD, Sanjay K Banerjee, Subham Banerjee iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.5c00808 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Ankan Das und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, Assam 781101, India. Hauptthemen laut MEDLINE: Printing, Three-Dimensional, Acyclovir. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Conventional treatment of herpetic keratitis via eye drops or ointments is limited by rapid precorneal elimination, frequent dosing requirements, and poor patient adherence. To overcome these challenges, this study explores the use of single-step direct powder extrusion (DPE) 3D printing for the fabrication of sustained-release, dissolvable ocular inserts composed of acyclovir, hydroxypropyl methylcellulose acetate succinate-high flow (HPMCAS-HF), and polyethylene glycol (PEG) 6000. Inserts were printed with varying infill densities (30%, 60%, and 90%) to modulate microstructural properties, drug release profiles, and transcorneal permeation. Lower infill density (OI30) exhibited higher porosity, enabling rapid matrix erosion and diffusion-driven release (∼95% over 24 h), along with enhanced permeation flux (0.33 ± 0.01 μg/cm2/min) and permeation coefficient (1.14 ± 0.05 × 10-2 cm/s). Conversely, high-density constructs (OI90) showed compact microstructure, slower erosion (∼40% at 10 h), and extended release (∼58% over 24 h) with reduced transcorneal permeation flux (0.15 ± 0.01 μg/cm2/min). All formulations followed Weibull release kinetics (R2 > 0.98), demonstrating a complex diffusion- and erosion-driven release behavior. The inserts maintained physiological pH, desired flexibility, and exhibited high biocompatibility in both in vitro and ex vivo studies, with no observable signs of irritancy in the hen's egg test on chorioallantoic membrane (HET-CAM), excellent hemocompatibility, >80% viability of ARPE-19 cells, and desired corneal tolerance. Apart from these, the 3D-printed ocular insert showed nearly 4-fold enhanced penetration and retention of Rhodamine B in the corneal layers compared to its aqueous solution during confocal laser scanning microscopy (CLSM) studies. These findings confirm the potential of DPE 3D printing for producing customizable, patient-centric, bioerodible ocular drug delivery systems offering sustained and tailored release, improved retention, and enhanced compliance for the management of keratitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Printing, Three-DimensionalAcyclovirAnimalsDrug LiberationPowdersKeratitis, HerpeticCorneaDelayed-Action PreparationsDrug Delivery SystemsHumansOphthalmic SolutionsPolyethylene GlycolsAdministration, OphthalmicPorosityChorioallantoic MembraneChick Embryo

Stichwörter der Autor:innen

3D printingacyclovirdirect powder extrusionocular insertstailored drug delivery

Substanzen

AcyclovirPowdersDelayed-Action PreparationsOphthalmic SolutionsPolyethylene Glycols

Autor:innen und Institutionen

  • Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, Assam 781101, India.
  • Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, Assam 781101, India.

ORCID-Profile: Shriram Mahajan, Subham Banerjee

Zitieren

APA

Das, A., Lekurwale, S., Mahajan, S., Banerjee, S. K., & Banerjee, S. (2025). Infill-Modulated, Bioerodible, and Biocompatible Ocular Inserts for Tunable Acyclovir Release via Direct Powder Extrusion 3D Printing. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00808

Vancouver

Das A, Lekurwale S, Mahajan S, Banerjee SK, Banerjee S. Infill-Modulated, Bioerodible, and Biocompatible Ocular Inserts for Tunable Acyclovir Release via Direct Powder Extrusion 3D Printing. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00808

BibTeX
@article{Das2025,
  author = {Das, Ankan and Lekurwale, Srushti and Mahajan, Shriram and Banerjee, Sanjay K and Banerjee, Subham},
  title = {Infill-Modulated, Bioerodible, and Biocompatible Ocular Inserts for Tunable Acyclovir Release via Direct Powder Extrusion 3D Printing},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.5c00808}
}
Kostenlos starten →